NR667- CEA FNP (2025) Actual Exam Questions
and Answers A+ Graded
1. A .patient .currently .undergoing .concurrent .chemotherapy/radiation .treat-
.ment .for .glottic .squamous .cell .carcinoma .is .admitted .to .the .rehab .unit .you
.oversee .for .management .of .intractable .nausea, .vomiting, .and .dehydration.
. Admission .CBC .showed .WBC .1.3, .Hgb .7.5, .PLT .45, .ANC .0.8. .Which .of .the
.following .conditions .is .this .patient .at .risk .for?
A. Macrocytic .anemia .due .to .B12 .deficiency
B. Iron .deficiency .anemia .due .to .chronic .blood .loss
C. Microcytic .anemia .due .to .chronic .kidney .disease
D. Aplastic .anemia .due .to .bone .marrow .suppression: .D
2. Your .patient .presents .to .the .urgent .care .clinic .with .a .swollen .exudative
.pharynx, .profound .fatigue, .and .a .very .tender .left .upper .quadrant .abdomen.
.What .is .the .most .likely .diagnosis?
A. Strep .pharyngitis
B. Tonsillitis
C. Epstein .Barr .virus .(EBV)
D. Pancreatitis: .C
3. Which .of .the .following .best .characterizes .presbycusis .in .the .older .adult?
A. Bilateral .low-frequency .sensorineural .hearing .loss
B. Bilateral .high-frequency .sensorineural .hearing .loss
C. Unilateral .high-frequency .sensorineural .hearing .loss
D. Unilateral .low-frequency .sensorineural .hearing .loss: .B
4. A .35-year-old .woman .presents .with .allergic .rhinitis, .experiencing .significant
.nasal .congestion, .sneezing, .and .itchy .eyes. .She .has .tried .over-the-counter
.antihistamines .with .limited .relief. .What .is .the .most .appropriate .next .step .in
.management?
A. Oral .decongestants
B. Nasal .saline .irrigation
C. Intranasal .corticosteroids
,D. Referral .to .an .allergist .for .immunotherapy: .C
5. A .patient .currently .undergoing .concurrent .chemotherapy/radiation .treat-
.ment .for .glottic .squamous .cell .carcinoma .is .admitted .to .the .rehab .unit .you
.oversee .for .management .of .intractable .nausea, .vomiting, .and .dehydration.
. Admission .CBC .showed .WBC .1.3, .Hgb .7.5, .PLT .45, .ANC .0.8. .Which .of .the
.following .conditions .is .this .patient .at .risk .for?
,A. Iron .deficiency .anemia .due .to .chronic .blood .loss
B. Microcytic .anemia .due .to .chronic .kidney .disease
C. Macrocytic .anemia .due .to .B12 .deficiency
D. Aplastic .anemia .due .to .bone .marrow .suppression: .D
6. A .78 .y.o. .M .patient .reports .chronic .infections, .bruising, .fatigue, .SOB, .and
.fevers. .He .has .a .history .of .rectal .adenocarcinoma .and .completed .concurrent
.chemotherapy/radiation .earlier .this .year. .His .CBC .shows .Hgb .7.5, .PLT .88,.WBC
.1.2, .ANC .0.8, .and .peripheral .smear .shows .dysplasia..What .additional .work-up
.would .you .anticipate .for .this .patient?
A. Colonoscopy .and .fecal .occult .blood .test
B. Bone .marrow .biopsy .and .flow .cytometry
C. No .additional .work-up .is .required, .these .are .expected .sequela .of .his .onco-
.logic .treatment
D. Repeat .CBC/CMP/peripheral .smear .in .eight .weeks: .B
7. Progression .to .Acute .Myelogenous .Leukemia .(AML) .is .a .risk .for .untreated
.or .poorly .responsive:
A. Pancytopenia
B. Aplastic .anemia
C. Macrocytic .anemia
D. Myelodysplastic .syndrome: .D
8. Treatment .for .symptomatic .aplastic .anemia .includes .all .the .following .ex-
.cept:
A. Bone .marrow .transplant
B. PRBC/Platelet/WBC .transfusions
C. Prophylactic .antibiotics
D. Removal .of .bone .marrow .stimulants: .D
9. A .patient .diagnosed .with .iron .deficiency .anemia .requires .iron .supplemen-
.tation. .Which .of .the .following .treatments .would .likely .be .ineffective?
A. Ferrous .sulfate .325 .mg .PO .BID .for .a .43 .y.o. .F .s/p .gastric .bypass .2 .years .ago
B. Iron .sucrose .200 .mg .IV .infusion .weekly .x .8 .weeks .in .a .26 .y.o. .F .at .34 .weeks
.of .pregnancy
C. Ferrous .sulfate .325 .mg .PO .TID .for .a .25 .y.o. .F .with .menorrhagia
D. Ferrous .sulfate .325 .mg .PO .BID .for .a .63 .y.o. .M .with .ulcerative .colitis: .A
10. Which .of .the .following .is .not .a .common .mechanism .of .neutrophil .expen-
.diture .and .resultant .neutropenia?
, A. Decreased .neutrophil .production .in .the .bone .marrow
B. Redistribution .of .neutrophils .to .the .spleen .or .vascular .endothelium
C. Loss .of .circulating .neutrophils .in .acute .blood .loss
D. Immune .destruction: .C
11. Which .of .the .following .blood .lead .levels .(BLL) .would .likely .require .chela-
.tion .therapy?
A. < .80 .mcg/dL
B. 35 .mcg/dL
C. >100 .mcg/dL
D. 75 .mcg/dL: .C
12. A .geriatric .patient .with .anemia, .back .pain, .osteoporosis, .and .elevated
.erythrocyte .sedimentation .rate .should .be .evaluated .for:
A. cauda .equina .syndrome.
B. renal .dystrophy.
C. Paget's .disease.
D. multiple .myeloma.: .D
13. Overactivation .of .coagulation .and .fibrinolysis .resulting .in .thrombosis .and
.hemorrhage .is .a .trademark .of .which .of .the .following?
A. Thrombocytopenia
B. Aplastic .anemia
C. Myelodysplastic .syndrome
D. Disseminated .intravascular .coagulation: .D
14. A .patient .on .warfarin .(Coumadin) .therapy .for .recurrent .deep .vein .thrombo-
.sis .(DVT) .is .about .to .have .lumbar .spinal .fusion .surgery..The .patient's .warfarin
.is .put .on .hold .starting .5 .days .prior .to .the .surgery .and .subcutaneous .enoxa-
.parin .(Lovenox) .has .been .ordered .for .DVT .prophylaxis .until .the .resumption
.of .the .warfarin..The .nurse .practitioner .knows .that .the .patient's .postoperative
.warfarin .dose .should .be .restarted .based .on .the:
A. Value .of .her .morning .Prothrombin .time
B. baseline .PT .and .INR .values
C. target .INR .of .2.5
D. Loading .dose .of .20 .mg, .plus .the .previous .warfarin .dose: .B
15. Your .patient .presented .yesterday .to .urgent .care .with .symptoms .of .lower
.extremity .weakness .and .then .went .home .for .observation .with .family. .They
and Answers A+ Graded
1. A .patient .currently .undergoing .concurrent .chemotherapy/radiation .treat-
.ment .for .glottic .squamous .cell .carcinoma .is .admitted .to .the .rehab .unit .you
.oversee .for .management .of .intractable .nausea, .vomiting, .and .dehydration.
. Admission .CBC .showed .WBC .1.3, .Hgb .7.5, .PLT .45, .ANC .0.8. .Which .of .the
.following .conditions .is .this .patient .at .risk .for?
A. Macrocytic .anemia .due .to .B12 .deficiency
B. Iron .deficiency .anemia .due .to .chronic .blood .loss
C. Microcytic .anemia .due .to .chronic .kidney .disease
D. Aplastic .anemia .due .to .bone .marrow .suppression: .D
2. Your .patient .presents .to .the .urgent .care .clinic .with .a .swollen .exudative
.pharynx, .profound .fatigue, .and .a .very .tender .left .upper .quadrant .abdomen.
.What .is .the .most .likely .diagnosis?
A. Strep .pharyngitis
B. Tonsillitis
C. Epstein .Barr .virus .(EBV)
D. Pancreatitis: .C
3. Which .of .the .following .best .characterizes .presbycusis .in .the .older .adult?
A. Bilateral .low-frequency .sensorineural .hearing .loss
B. Bilateral .high-frequency .sensorineural .hearing .loss
C. Unilateral .high-frequency .sensorineural .hearing .loss
D. Unilateral .low-frequency .sensorineural .hearing .loss: .B
4. A .35-year-old .woman .presents .with .allergic .rhinitis, .experiencing .significant
.nasal .congestion, .sneezing, .and .itchy .eyes. .She .has .tried .over-the-counter
.antihistamines .with .limited .relief. .What .is .the .most .appropriate .next .step .in
.management?
A. Oral .decongestants
B. Nasal .saline .irrigation
C. Intranasal .corticosteroids
,D. Referral .to .an .allergist .for .immunotherapy: .C
5. A .patient .currently .undergoing .concurrent .chemotherapy/radiation .treat-
.ment .for .glottic .squamous .cell .carcinoma .is .admitted .to .the .rehab .unit .you
.oversee .for .management .of .intractable .nausea, .vomiting, .and .dehydration.
. Admission .CBC .showed .WBC .1.3, .Hgb .7.5, .PLT .45, .ANC .0.8. .Which .of .the
.following .conditions .is .this .patient .at .risk .for?
,A. Iron .deficiency .anemia .due .to .chronic .blood .loss
B. Microcytic .anemia .due .to .chronic .kidney .disease
C. Macrocytic .anemia .due .to .B12 .deficiency
D. Aplastic .anemia .due .to .bone .marrow .suppression: .D
6. A .78 .y.o. .M .patient .reports .chronic .infections, .bruising, .fatigue, .SOB, .and
.fevers. .He .has .a .history .of .rectal .adenocarcinoma .and .completed .concurrent
.chemotherapy/radiation .earlier .this .year. .His .CBC .shows .Hgb .7.5, .PLT .88,.WBC
.1.2, .ANC .0.8, .and .peripheral .smear .shows .dysplasia..What .additional .work-up
.would .you .anticipate .for .this .patient?
A. Colonoscopy .and .fecal .occult .blood .test
B. Bone .marrow .biopsy .and .flow .cytometry
C. No .additional .work-up .is .required, .these .are .expected .sequela .of .his .onco-
.logic .treatment
D. Repeat .CBC/CMP/peripheral .smear .in .eight .weeks: .B
7. Progression .to .Acute .Myelogenous .Leukemia .(AML) .is .a .risk .for .untreated
.or .poorly .responsive:
A. Pancytopenia
B. Aplastic .anemia
C. Macrocytic .anemia
D. Myelodysplastic .syndrome: .D
8. Treatment .for .symptomatic .aplastic .anemia .includes .all .the .following .ex-
.cept:
A. Bone .marrow .transplant
B. PRBC/Platelet/WBC .transfusions
C. Prophylactic .antibiotics
D. Removal .of .bone .marrow .stimulants: .D
9. A .patient .diagnosed .with .iron .deficiency .anemia .requires .iron .supplemen-
.tation. .Which .of .the .following .treatments .would .likely .be .ineffective?
A. Ferrous .sulfate .325 .mg .PO .BID .for .a .43 .y.o. .F .s/p .gastric .bypass .2 .years .ago
B. Iron .sucrose .200 .mg .IV .infusion .weekly .x .8 .weeks .in .a .26 .y.o. .F .at .34 .weeks
.of .pregnancy
C. Ferrous .sulfate .325 .mg .PO .TID .for .a .25 .y.o. .F .with .menorrhagia
D. Ferrous .sulfate .325 .mg .PO .BID .for .a .63 .y.o. .M .with .ulcerative .colitis: .A
10. Which .of .the .following .is .not .a .common .mechanism .of .neutrophil .expen-
.diture .and .resultant .neutropenia?
, A. Decreased .neutrophil .production .in .the .bone .marrow
B. Redistribution .of .neutrophils .to .the .spleen .or .vascular .endothelium
C. Loss .of .circulating .neutrophils .in .acute .blood .loss
D. Immune .destruction: .C
11. Which .of .the .following .blood .lead .levels .(BLL) .would .likely .require .chela-
.tion .therapy?
A. < .80 .mcg/dL
B. 35 .mcg/dL
C. >100 .mcg/dL
D. 75 .mcg/dL: .C
12. A .geriatric .patient .with .anemia, .back .pain, .osteoporosis, .and .elevated
.erythrocyte .sedimentation .rate .should .be .evaluated .for:
A. cauda .equina .syndrome.
B. renal .dystrophy.
C. Paget's .disease.
D. multiple .myeloma.: .D
13. Overactivation .of .coagulation .and .fibrinolysis .resulting .in .thrombosis .and
.hemorrhage .is .a .trademark .of .which .of .the .following?
A. Thrombocytopenia
B. Aplastic .anemia
C. Myelodysplastic .syndrome
D. Disseminated .intravascular .coagulation: .D
14. A .patient .on .warfarin .(Coumadin) .therapy .for .recurrent .deep .vein .thrombo-
.sis .(DVT) .is .about .to .have .lumbar .spinal .fusion .surgery..The .patient's .warfarin
.is .put .on .hold .starting .5 .days .prior .to .the .surgery .and .subcutaneous .enoxa-
.parin .(Lovenox) .has .been .ordered .for .DVT .prophylaxis .until .the .resumption
.of .the .warfarin..The .nurse .practitioner .knows .that .the .patient's .postoperative
.warfarin .dose .should .be .restarted .based .on .the:
A. Value .of .her .morning .Prothrombin .time
B. baseline .PT .and .INR .values
C. target .INR .of .2.5
D. Loading .dose .of .20 .mg, .plus .the .previous .warfarin .dose: .B
15. Your .patient .presented .yesterday .to .urgent .care .with .symptoms .of .lower
.extremity .weakness .and .then .went .home .for .observation .with .family. .They
